Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Bhaskar, V., Yin, J., Mirza, A. M, Phan, D., Vanegas, S., Issafras, H., Michelson, K., Hunter, J. J, & Kantak, S. S Atherosclerosis, 216(2):313–20, June, 2011.
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. [link]Paper  bibtex   

Downloads: 0